• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中和抗体GNbAC1可消除人内源性逆转录病毒-W包膜蛋白介导的少突胶质细胞成熟阻滞。

The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.

作者信息

Kremer David, Förster Moritz, Schichel Tanja, Göttle Peter, Hartung Hans-Peter, Perron Hervé, Küry Patrick

机构信息

Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany/These authors contributed equally to this study.

Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

出版信息

Mult Scler. 2015 Aug;21(9):1200-3. doi: 10.1177/1352458514560926. Epub 2014 Dec 5.

DOI:10.1177/1352458514560926
PMID:25480862
Abstract

BACKGROUND

The envelope protein (ENV) of the human endogenous retrovirus type W is implicated in inflammatory reactions in multiple sclerosis (MS) but also interferes with oligodendroglial maturation. A neutralizing antibody GNbAC1 has been developed and successfully been tested in clinical trials.

OBJECTIVES AND METHODS

We stimulated primary oligodendroglial cells with ENV upon preincubation with GNbAC1 and assessed for nitrosative stress and myelin expression.

RESULTS

Neutralization of ENV by GNbAC1 reduces its ability to induce stress reactions resulting in a rescue of myelin expression.

CONCLUSIONS

Beyond immune cell modulation, this monoclonal antibody may therefore help to overcome the oligodendroglial differentiation blockade in MS.

摘要

背景

人类内源性W型逆转录病毒的包膜蛋白(ENV)与多发性硬化症(MS)的炎症反应有关,但也会干扰少突胶质细胞的成熟。一种中和抗体GNbAC1已被研发出来,并在临床试验中成功进行了测试。

目的和方法

我们在GNbAC1预孵育后用ENV刺激原代少突胶质细胞,并评估亚硝化应激和髓鞘表达情况。

结果

GNbAC1对ENV的中和作用降低了其诱导应激反应的能力,从而挽救了髓鞘表达。

结论

因此,除了免疫细胞调节作用外,这种单克隆抗体可能有助于克服MS中少突胶质细胞分化阻滞的问题。

相似文献

1
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.中和抗体GNbAC1可消除人内源性逆转录病毒-W包膜蛋白介导的少突胶质细胞成熟阻滞。
Mult Scler. 2015 Aug;21(9):1200-3. doi: 10.1177/1352458514560926. Epub 2014 Dec 5.
2
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.靶向内源性逆转录病毒MSRV-Env蛋白的人源化IgG4单克隆抗体GNbAC1的临床前和早期临床开发。
MAbs. 2015;7(1):265-75. doi: 10.4161/19420862.2014.985021.
3
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.MSRV包膜蛋白是人类 Toll 样受体 4 的一种强效、内源性致病激动剂:GNbAC1 在多发性硬化症治疗中的相关性。
J Neuroimmunol. 2016 Feb 15;291:29-38. doi: 10.1016/j.jneuroim.2015.12.006. Epub 2015 Dec 11.
4
Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination.挽救人类内源性逆转录病毒包膜蛋白对少突胶质细胞分化和髓鞘形成的负面影响。
Glia. 2019 Jan;67(1):160-170. doi: 10.1002/glia.23535. Epub 2018 Nov 14.
5
A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody.一种治疗 1 型糖尿病的新方法:抗 HERV-W-Env 单克隆抗体 GNbAC1 的原理。
Diabetes Obes Metab. 2018 Sep;20(9):2075-2084. doi: 10.1111/dom.13357. Epub 2018 Jun 10.
6
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.针对多发性硬化症相关内源性逆转录病毒包膜蛋白的人源化单克隆抗体 GNbAC1:一项首次人体随机临床试验。
Clin Ther. 2012 Dec;34(12):2268-78. doi: 10.1016/j.clinthera.2012.11.006. Epub 2012 Nov 29.
7
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up.一项IIa期随机临床研究,在多发性硬化症患者中测试GNbAC1(一种针对多发性硬化症相关内源性逆转录病毒包膜蛋白的人源化单克隆抗体)——为期十二个月的随访。
J Neuroimmunol. 2015 Aug 15;285:68-70. doi: 10.1016/j.jneuroim.2015.05.019. Epub 2015 May 20.
8
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.一项针对多发性硬化症患者的IIa期随机临床研究,该研究使用了GNbAC1,一种针对与多发性硬化症相关的内源性逆转录病毒包膜蛋白的人源化单克隆抗体。
Mult Scler. 2015 Jun;21(7):885-93. doi: 10.1177/1352458514554052. Epub 2014 Nov 12.
9
Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation.人类内源性逆转录病毒 W 型包膜蛋白抑制少突胶质前体细胞分化。
Ann Neurol. 2013 Nov;74(5):721-32. doi: 10.1002/ana.23970. Epub 2013 Sep 16.
10
Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.针对人类内源性逆转录病毒的治疗:一种针对多发性硬化症的个性化医疗方法。
Mol Diagn Ther. 2015 Oct;19(5):255-65. doi: 10.1007/s40291-015-0166-z.

引用本文的文献

1
Persistent type I interferon signaling within the brain of people with HIV on ART with cognitive impairment.在接受抗逆转录病毒治疗且有认知障碍的HIV感染者大脑中,I型干扰素信号持续存在。
PLoS Pathog. 2025 Aug 20;21(8):e1013411. doi: 10.1371/journal.ppat.1013411. eCollection 2025 Aug.
2
Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders.人类内源性逆转录病毒作为神经退行性疾病的新型治疗靶点
Vaccines (Basel). 2025 Apr 15;13(4):415. doi: 10.3390/vaccines13040415.
3
Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects.
多发性硬化症:当前药物治疗及新兴治疗前景的叙述性综述。
Pharmacol Rep. 2024 Oct;76(5):926-943. doi: 10.1007/s43440-024-00642-0. Epub 2024 Aug 23.
4
The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases.微生物在脱髓鞘疾病病因发病机制中的作用
Life (Basel). 2023 Jun 1;13(6):1309. doi: 10.3390/life13061309.
5
SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients.严重急性呼吸综合征冠状病毒2激活了古代逆转录病毒基因,并使新冠患者体内促炎的人内源性逆转录病毒-W包膜蛋白表达。
iScience. 2023 May 19;26(5):106604. doi: 10.1016/j.isci.2023.106604. Epub 2023 Apr 7.
6
Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation.西尼莫德调节小胶质细胞对促炎刺激的反应。
Int J Mol Sci. 2022 Oct 31;23(21):13278. doi: 10.3390/ijms232113278.
7
Transcriptional Regulation of Endogenous Retroviruses and Their Misregulation in Human Diseases.内源性逆转录病毒的转录调控及其在人类疾病中的失调
Int J Mol Sci. 2022 Sep 4;23(17):10112. doi: 10.3390/ijms231710112.
8
Antibody Response to HML-2 May Be Protective in Amyotrophic Lateral Sclerosis.针对 HML-2 的抗体反应可能对肌萎缩侧索硬化症具有保护作用。
Ann Neurol. 2022 Nov;92(5):782-792. doi: 10.1002/ana.26466. Epub 2022 Aug 24.
9
Human endogenous retroviruses (HERV) and non-HERV viruses incorporated into the human genome and their role in the development of autoimmune diseases.整合到人类基因组中的人类内源性逆转录病毒(HERV)和非HERV病毒及其在自身免疫性疾病发展中的作用。
J Transl Autoimmun. 2021 Dec 9;4:100137. doi: 10.1016/j.jtauto.2021.100137. eCollection 2021.
10
TLR4 Associated Signaling Disrupters as a New Means to Overcome HERV-W Envelope-Mediated Myelination Deficits.TLR4相关信号干扰因子作为克服内源性逆转录病毒-W包膜介导的髓鞘形成缺陷的新手段
Front Cell Neurosci. 2021 Nov 23;15:777542. doi: 10.3389/fncel.2021.777542. eCollection 2021.